Deep vein thrombosis (DVT) and pulmonary embolism (PE) represent serious complications of orthopedic surgery. The risk for these complications is greatest during surgery of the inferior limb, in particular of the hip and knee. The frequency of thromboembolic disease is difficult to specify, because its diagnosis is difficult on the basis of clinical data alone; as much as 70% of DVT and 20% of PE are asymptomatic, but these events are fatal in 1.0%-3.5% of cases [1] [2] [3] [4] . In 1952, Stulz and Froelich [5] recommended systematic prophylaxis for thromboembolic complications in all traumatized patients. In 1959, Sevitt and Gallagher [6] underlined the prevention of these pathologies. In 1986, the NIH Consensus Conference [7], the first of its kind, recommended pharmacological prophylaxis with heparin, warfarin and dextran, according to the characteristics of the patient. Nevertheless, prophylaxis does not eliminate the risk of thromboembolism [4, [8] [9] [10] [11] . Therefore it is necessary to identify patients at risk before operation, and to suspect its onset at the first symptoms.
remaining 10 patients through the femoral vein of the contralateral limb. This approach improved the placement of the filter tail with subsequent better stability of the basket within the vena cava. The filter's position was monitored daily using standard radiography of the abdomen. Additionally, we performed venocavography every 48 h through the actual filter to identify the eventual presence of thrombi within the basket, to monitor the flow of blood within the vein, and to check the position of the filter.
Patients received either general anesthesia (11 cases) or spinal anesthesia (19 cases) . During anesthesia, the patients were maintained in controlled hypotension. We used the cemented total hip prosthesis LC (Samo, Bologna, Italy) in 14 patients and the noncemented prosthesis Antega (Aesculap, Tüttlingen, Germany) in 16 patients. Arthroplasty was performed using the lateral approach with the patients in lateral decubitus position. Access to the joint was through the musculi gluteus minimus and medius, the femoral head was in anterior luxation, and the limb dangled from the surgical bed in abduction and maximal external rotation.
Postoperative protocol
Patients were assisted in mobilizing the operated limb starting on the first postoperative day. Suction drains were removed from the surgical wound on day 3, and elastic stockings for vascular support were applied. Active mobilization was permitted on day 4. On the sixth postoperative day, after removal of the vena cava filter, the patients began weight-bearing and ambulation assisted with a walker. All patients underwent pulmonary perfusional scintigraphy on the seventh day following operation.
Results
The two groups of patients were similar in terms of postoperative outcome, time to weight-bearing, and subjective satisfaction. A total of 5 patients, all of whom received the vena cava filter, had a history of post-surgical PE. The operation lasted 45-65 min (mean, 50 min in Group A and 55 min in Group B) ( Table 1) .
On venocavography, the vena cava filter was found to be filled with thrombus-like material in 3 patients (Fig. 2) . To prevent hemorraghic suffusion and lower limb edema, we chose to substitute the Filcard filter with another filter of the same characteristics (Angiocor, Cordis, J&J). This choice was motivated by the availability of the second filter type. Fibrinolysis was performed in only 1 of these 3 cases.
There was one case of DVT in group A, in an 83-year-old woman who had received a cemented prosthesis under general anesthesia. On the second postoperative day, after venocavography, we performed fibrinolysis of the material in the basket using urokinase (4000 IU/kg body weight). This resulted in increased bleeding with hemorrhagic suffusion and lower limb edema. On the fourth day, DVT was documented clinically and on Doppler ultrasonography. After
Patients and methods

Patients
At the Orthopedics Clinic of the University of Genoa, we conducted an open, randomized clinical trial involving 30 patients undergoing total hip arthroplasty for coxarthrosis. Eligible patients were 65 years of age or older, and had medium to severe venous insufficiency of the lower limbs.
Vena cava filter
We used the teflon and gold Filcard RFO2 vena cava filter (Filcard International, Lille, France). The filter contains a distal basket of 30-mm diameter that catches thrombi in the vena cava. The filter allows the administration of fibrinolytic therapy and the performance of venocavography (Fig. 1) . Surgery was performed by the same surgeon (F.P.) who used, in all patients, an identical technique; similarly, the pre-and post-surgical protocols were the same for all patients. Two hours prior to operation, all patients received anti-thromboembolic prophylaxis consisting of calcium heparin or low-molecular-weight heparin. In addition, patients received mechanical prophylaxis consisting of compressive vascular bandaging of the lower limbs during and after the operation for two months.
The patients were randomly divided into two groups of 15 persons. In group A, the vena cava filter was employed during hip arthroplasty; group B served as a negative control and received no filter. The vena cava filter was introduced one hour before surgery, by percutaneous route and followed under radiographic control. In 5 patients, the filter was inserted through the cephalic vein. However, because of a few instances of filter migration, it was inserted in the intravenous administration of heparin, there was complete recovery. The vena cava filter was removed on the fifth postoperative day.
As documented by pulmonary scintigraphy, there was no occurrence of PE in group A, but two occurrences in group B (control). In a 65-year-old woman who had received a non-cemented prosthesis under general anesthesia, PE occurred on day 6 in the basal lobe of the right lung. This patient did not have a history of post-surgical PE. The second case occurred in a 75-year-old woman with liver cirrhosis. She had experienced PE after abdominal surgery 2 years earlier. Five days after receiving a cemented prosthesis under spinal anesthesia, she experienced DVT with lower limb lymphangitis and subsequent PE. After intravenous administration of heparin, her condition improved.
Postoperative complications due to the use of the vena cava filter (Table 2) occurred only in those patients in whom the filter was inserted via transbrachial access. As mentioned previously, the filter was obstructed in 3 cases, requiring substitution in 2 patients and fibrinolysis therapy in 1 patient.
Discussion
In prosthetic surgery, the risk of thromboembolic complications depends on the patient, the pathology, the type of intervention and the postoperative care. Generally the risk of DVT is greatest during the first 13 postoperative days [9] . The risk of PE is mostly correlated with surgery of the lower limb [5] ; it manifests in the first week in 10% of cases, in the second week in 25%, and in the fourth and fifth weeks in 8% and 5% of cases, respectively [10] .
There are various pharmacological approaches to thromboembolic prophylaxis. Paiement et al. [13] compared the outcomes of patients receiving pharmacological prophylaxis (i.e. acetylsalicylic acid (ASA), warfarin and dextran) with those receiving external pneumatic compression or placebo. They showed surprising and debatable results: proximal DVT was prevented successfully in 45% of cases receiving placebo, in 40% and 60% of patients receiving ASA (35 and 300 mg/day), and in 19% of cases with pneumatic compression.
Wolf et al. [14] reported an incidence of PE of 6.2% and 33.9% when using non-cemented and cemented prostheses, respectively. According to Francis et al. [15] , there were no cases of DVT when using non-cemented prostheses while DVT occurred in 40% of patients receiving cemented prostheses. A surgical procedure longer than 90 min increased the risk of PE [15] . Planes et al. [16] and Warwick et al. [17] showed that, during preparation of the femoral canal, the forced position of the inferior limb can lead to the complete blockage of the circulation.
The Filcard filter has been tested clinically. Galli et al. [18] reported no complications or recurrences. Santoro et al. [19] reported a successful management of 20 patients with DVT at 10 months of follow-up. Lefebvre et al.
[20] presented a success rate of 76%-100% in an international multicentric study. Emanuelli et al.
[21] used the RFO2 filter for the prevention of PE during urologic and gynecologic surgeries. Our results are in accordance with these. The use of vena cava filters in 15 high-risk patients accomplished total prevention of PE. In our study, PE only occurred in 2 patients (13%) of the control group, while DVT occurred in 1 patient (7%) of each group. Vena cava filters are an effective means of preventing PE when used in patients at high risk for DVT; however, they must only be used according to specific indications. The ideal vena cava filter is characterized by: athrombogenicity, high filtration capacity without blocking the circulation, adaptability to the vessel walls, rapid and atraumatic positioning, easy release, controllable repositioning and removal, and contained cost. Currently, no one filter has all these characteristics, so routine use of the temporary filter is dissuaded. It is instead useful to reserve the use of these filters for cases of recurrent PE or for patients with thrombotic pathology.
